DOJ

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Retrieved on: 
Friday, March 1, 2024
Zio, Court, Boston Scientific, Marketing, FDA, J. P. Morgan, Advertising, Growth, IRTC, DOJ, Patient, LLP, Justice, Subpoena duces tecum, Pharmaceutical industry

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding iRhythm’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UnitedHealth Group Incorporated - UNH

Retrieved on: 
Thursday, February 29, 2024
The Wall Street Journal, Pomerantz, Optum, Prior, News, UnitedHealth Group, DOJ, UNH, WSJ

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).

Key Points: 
  • NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).
  • 7980
    The investigation concerns whether UnitedHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On February 27, 2024, The Wall Street Journal (“WSJ”) reported that the U.S. Department of Justice (“DOJ”) has launched an antitrust investigation into UnitedHealth.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Calavo Growers, Inc. - CVGW

Retrieved on: 
Wednesday, February 28, 2024
Pomerantz, Late, Special, News, Committee, DOJ, LLP, Bank statement

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Calavo Growers, Inc. (“Calavo” or the “Company”) (NASDAQ: CVGW).

Key Points: 
  • NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Calavo Growers, Inc. (“Calavo” or the “Company”) (NASDAQ: CVGW).
  • The investigation concerns whether Calavo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Cummins Inc. - CMI

Retrieved on: 
Wednesday, February 28, 2024
Pomerantz, Court, News, Biophysical environment, Complaint, CMI, Ext, DOJ, Certification, LLP, Action Replay

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cummins Inc. (“Cummins” or the “Company”) (NYSE: CMI).

Key Points: 
  • NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cummins Inc. (“Cummins” or the “Company”) (NYSE: CMI).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether Cummins Solutions and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

Retrieved on: 
Wednesday, February 28, 2024
Pomerantz, Zio, Court, Letter, FDA, Prior, News, Complaint, Ext, DOJ, Patient, Form FDA 483, LLP, Action Replay, Cryptocurrency

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC).

Key Points: 
  • NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC).
  • The class action concerns whether iRhythm and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • You have until April 8, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired iRhythm securities during the Class Period.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, February 28, 2024
Bitcoin, Geisler, Research, News, Growth, Sale, AUV, Atrial fibrillation, Mergers and acquisitions, Acceleration, P.C, Boston Scientific, Amplitude, Marketing, J. P. Morgan, Stroke, Heart failure, Bankruptcy, DOJ, Subpoena duces tecum, Data mining, Vii, ECG, IRTC, Zio, FDA, SSS, Hut 8, COVID-19, Bloomberg Businessweek, Patient, Defendant, Justice, Cryptocurrency

The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.

Key Points: 
  • The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.
  • The Zio XT is intended for non-critical patients, as it does not provide real-time reporting.
  • These types of heart monitors that are approved for high-risk patients and provide near real-time alerts are also referred to as “real-time” monitors.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.

SP Plus Corporation Announces Fourth Quarter and Full-Year 2023 Results

Retrieved on: 
Tuesday, February 27, 2024
Acquisition, Sphere, SP, Plan, Metropolis, Investment, Second request, Growth, Disclosure, GAAP, DOJ, EPS, G&A, Agreement, Depreciation, Video game

CHICAGO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SP® Plus Corporation (Nasdaq:SP), a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, today announced its fourth quarter and full year 2023 results.

Key Points: 
  • Fourth quarter 2023 reported general and administrative (“G&A”) expenses were $40.4 million, compared to $30.7 million in the year ago quarter.
  • Fourth quarter 2023 reported net income attributable to SP Plus was $1.2 million, or $0.06 per diluted share, compared to $4.8 million, or $0.24 per diluted share in the year ago quarter.
  • Fourth quarter 2023 adjusted earnings per share were $0.60, compared to adjusted earnings per share of $0.56 for the fourth quarter of 2022.
  • In light of the pending acquisition by Metropolis Technologies, Inc., and as is customary during such transactions, SP+ will not host an earnings conference call for its fourth quarter 2023 results.

CMI SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Cummins Inc. (CMI)

Retrieved on: 
Tuesday, February 27, 2024
Court, Person, News, Fraud, CFTC, District court, CMI, Lead, Medicare, DOJ, IRS, Certification, EPA, LLP, RAM, COPY, Pharmaceutical industry

RADNOR, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Cummins Inc. (“Cummins”) ( NYSE: CMI ).

Key Points: 
  • RADNOR, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Cummins Inc. (“Cummins”) ( NYSE: CMI ).
  • The action charges Cummins with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Cummins’ s materially misleading statements and omissions to the public, Cummins’ s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Cummins investors who have suffered significant losses to contact the firm directly to acquire more information.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, February 24, 2024
Bitcoin, Geisler, Research, News, Growth, Sale, AUV, Atrial fibrillation, Mergers and acquisitions, Acceleration, P.C, Boston Scientific, Amplitude, Marketing, J. P. Morgan, Stroke, Heart failure, Bankruptcy, DOJ, Subpoena duces tecum, Data mining, Vii, ECG, IRTC, Zio, FDA, SSS, Hut 8, COVID-19, Bloomberg Businessweek, Patient, Defendant, Justice, Cryptocurrency

The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.

Key Points: 
  • The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.
  • The Zio XT is intended for non-critical patients, as it does not provide real-time reporting.
  • These types of heart monitors that are approved for high-risk patients and provide near real-time alerts are also referred to as “real-time” monitors.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.

IRHYTHM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options

Retrieved on: 
Friday, February 23, 2024
Zio, Court, Boston Scientific, Marketing, FDA, J. P. Morgan, Advertising, Growth, Woman, IRTC, DOJ, Patient, LLP, Justice, Subpoena duces tecum, Pharmaceutical industry

NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) and reminds investors of the April 8, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points: 
  • If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022, and May 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
  • Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding iRhythm’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.